Clinical Trial Update: A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating XZP-3287 in combination with letrozole or anastrozole for advanced breast cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Letrozole (letrozole)
• XZP-3287

Snippet

Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING